Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.43 | 6e-10 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.45 | 0.0004 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |